OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
February 22, 2018
The company aims to add the additional analytical services in the European Union throughout 2018.
February 21, 2018
Automation systems, vehicles, and robots improve efficiency of transporting materials and finished goods in pharmaceutical warehouses.
February 20, 2018
A new suite for the encapsulation of highly potent drugs will be added.
February 13, 2018
Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.
A $800-million acquisition of MPI Research expands Charles River's offerings for early-stage contract research.
February 09, 2018
The companies will partner to further immuno-oncology research using humanized mice.
February 02, 2018
Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.
Hospitals form not-for-profit drug company to combat drug shortages and high prices.
Mark Egerton, PhD, chief executive officer of Quotient Sciences, shares insights on a new approach to accelerate drug development, which integrates formulation development, real-time adaptive GMP manufacturing, and clinical research within a single platform.
Industry lessons from a fast-track technology transfer of a soft-gelatin capsule (softgel) are multifold. This case study reviews the success factors for effective execution of the technology transfer, which include: strong relationship between the customer, the contract development and manufacturing organization, and other partners based on deep knowledge in the technology; established and proven quality-by-design processes; risk mitigation management; project leadership; flawless execution; and mutual trust.